University of Alabama at Birmingham: COVID-19 trials

The registry lists 12 COVID-19 studies with University of Alabama at Birmingham as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 1 1Phase 2 4Phase 3 2No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Long COVID Brain Fog: Cognitive Rehabilitation TrialRecruitingNCT06095297Not applicable
• Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS)CompletedNCT04581811Not applicableResults posted
• COVID-19 Study of Safety and Tolerability of AlvelestatCompletedNCT04539795Phase 1/2Results posted
• Early Treatment of Cytokine Storm Syndrome in Covid-19CompletedNCT04362111Phase 3Results posted
• TXA and Corona Virus 2019 (COVID19) in OutpatientsTerminatedNCT04338074Phase 2Results posted
• COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)CompletedNCT04818853
• Restoration of Endothelial Integrity in Patients With COVID-19 (RELIC)WithdrawnNCT04723589Phase 2
• Improving Thinking in Everyday Life After Covid-19CompletedNCT04644172Not applicable
• VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 DiseaseCompletedNCT04587323
• Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 ExposureWithdrawnNCT04550338Phase 3
• Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in InpatientsWithdrawnNCT04338126Phase 2
• High Resolution Micro OCT ImagingActive, not recruitingNCT03256773